Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious […]
Targovax Granted European Patent for ONCOS-102 in Combination with Chemotherapy
Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat […]
Researchers Investigate New Treatment for Diabetes to Combat Sight Loss
Researchers at the University of Aberdeen are investigating a new treatment for diabetes which they […]
Pfizer and Biontech Expand Collaboration with U.S. to Provide 500 Million Additional Covid-19 Vaccine Doses at Not-for-profit Price for Donation to Poorest Countries
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to expand their […]
Think Tank Calls for Greater Focus on Vaccinating At-risk Groups Ahead of This Year’s Winter Flu Season
A new research report published today by the International Longevity Centre-UK (ILC) and commissioned by […]
Imfinzi Plus Chemotherapy Tripled Patient Survival at Three Years in the CASPIAN Phase III Trial in Extensive-stage Small Cell Lung Cancer
Updated results from the CASPIAN Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with a choice […]
SARS-CoV-2, Influenza A Inactivated by Zinc-embedded Nylon Fabric
An international team of scientists and engineers from the University of Cambridge, the Icahn School of […]
University of Oxford and Oracle Cloud System Helping Researchers Identify COVID-19 Variants Faster
The fast spread of the highly infectious Delta variant underscores the need for faster identification […]
Over One Million Invited For Covid Booster Jabs This Week
Invitations to book a Covid booster jab will be sent to one and a half […]
Elevian Raises $40 Million Series A to Advance Treatments for Stroke Recovery and Age-Related Diseases
Elevian, an emerging biotech company developing medicines that restore youthful regenerative capacity with the potential […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more